United Therapeutics Corp. (UTHR)
567.29
-1.29
(-0.23%)
USD |
NASDAQ |
May 18, 16:00
567.29
0.00 (0.00%)
After-Hours: 19:35
United Therapeutics Research and Development Expense (Quarterly) : 138.20M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| MannKind Corp. | 17.23M |
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| Insmed, Inc. | 209.48M |
| Amgen, Inc. | 1.719B |
| Ionis Pharmaceuticals, Inc. | 210.17M |